Press Releases
Novasep-PharmaZell Invests €7.3M to Increase API Production Capacity
The Novasep-PharmaZell Group has announced a €7.3M (approximately $7.45 USD) investment for its Mourenx, France site as part of a larger project supported by...
Drug Research
NICE Has Granted Its Endorsement To Beovu From Novartis
Following NICE's recommendation of a novel therapy alternative for diabetic macular oedema (DMO), thousands of patients could receive transformative care. In the final form...
White Papers
Solving Controlled Release Drug Delivery Challenges Using Extrusion-Spheronization
Overcome your controlled release drug delivery challenges through extrusion-spheronization
Combining best-in-class drug technology with a proven drug strategy
Extrusion-spheronization (E-S) is a robust technique that synchronizes...
Drug Research
Lilly, AZ, AbbVie, J&J May Be Hit By Medicare Pricing Bill
Could the Senate adopt a "watershed" bill allowing drug price discussions after years of government inaction regarding medication prices in the U.S.? Analysts are busy...
IT & Data Management
Cyclerion Provides Information On Schizophrenia Treatment
Positive top-line statistics from Cyclerion Therapeutics' clinical investigation of CY6463 for the treatment of cognitive impairment associated with schizophrenia have been released. It concerns...
Clinical Trials
Tallac Reveal They Have Served Their First TAC-001 Patient
In a phase 1/2 clinical trial for patients with locally advanced or metastatic solid tumours, Tallac Therapeutics has reported that the first patient has...
Drug Research
September May Bring Updated COVID-19 Booster Shots To Market
According to the US Department of Health and Human Services, booster shots from Moderna and Pfizer that have been upgraded to target Omicron coronavirus...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read